Inibidores de tirosino quinase contendo diarilacettleno hidrazida

inibidores de tirosino quinase contendo diarilacetileno hidrazida. a presente invenção refere-se a novos compostos de hidrazida diarylacetylene de fórmula (i) ou seu sal farmaceuticamente aceitável, tal como inibidores da tirosina quinase, o processo para a sua preparação, e à utilização dos compost...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DIPALI MANUBHAI DESAI, SABBIRHUSEN YUSUFBHAI CHIMANWALA, SENGUPTA PRABAL, VARUN ANILKUMAR MEHTA, HEMANT ASHVINBHAI CHOKSHI, THENNATI RAJAMANNAR, TRINADHA RAO CHITTURI, CHETAN SURJITSINGH PURI
Format: Patent
Sprache:por
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DIPALI MANUBHAI DESAI
SABBIRHUSEN YUSUFBHAI CHIMANWALA
SENGUPTA PRABAL
VARUN ANILKUMAR MEHTA
HEMANT ASHVINBHAI CHOKSHI
THENNATI RAJAMANNAR
TRINADHA RAO CHITTURI
CHETAN SURJITSINGH PURI
description inibidores de tirosino quinase contendo diarilacetileno hidrazida. a presente invenção refere-se a novos compostos de hidrazida diarylacetylene de fórmula (i) ou seu sal farmaceuticamente aceitável, tal como inibidores da tirosina quinase, o processo para a sua preparação, e à utilização dos compostos de fórmula geral (i) na preparação de composições farmacêuticas para o tratamento terapêutico de desordens relacionadas com a tirosina quinases, em animais de sangue quente. The present invention relates to novel diarylacetylene hydrazide compounds of formula (I) or pharmaceutically acceptable salt thereof, as tyrosine kinase inhibitors, the process for their preparation, and to the use of the compounds of formula (I) in the preparation of pharmaceutical compositions for the therapeutic treatment of disorders related to tyrosine kinases, in warm-blooded animals.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BR112013018212B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BR112013018212B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BR112013018212B13</originalsourceid><addsrcrecordid>eNqNyzEOwjAMQNEsDAi4QxZGpDpdWGkFghWxV6Y2wlJkl8QsnJ4OHIDpL-8vw-GicheywjUSR5diVdTi6y2KleNo6qxkkQSLZBzZPfMMnkIFP0K4DosH5sqbX1dhezre-vOOJxu4TvOi7EN3BUgNtA3sE6QO2n_dF-HZM-I</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Inibidores de tirosino quinase contendo diarilacettleno hidrazida</title><source>esp@cenet</source><creator>DIPALI MANUBHAI DESAI ; SABBIRHUSEN YUSUFBHAI CHIMANWALA ; SENGUPTA PRABAL ; VARUN ANILKUMAR MEHTA ; HEMANT ASHVINBHAI CHOKSHI ; THENNATI RAJAMANNAR ; TRINADHA RAO CHITTURI ; CHETAN SURJITSINGH PURI</creator><creatorcontrib>DIPALI MANUBHAI DESAI ; SABBIRHUSEN YUSUFBHAI CHIMANWALA ; SENGUPTA PRABAL ; VARUN ANILKUMAR MEHTA ; HEMANT ASHVINBHAI CHOKSHI ; THENNATI RAJAMANNAR ; TRINADHA RAO CHITTURI ; CHETAN SURJITSINGH PURI</creatorcontrib><description>inibidores de tirosino quinase contendo diarilacetileno hidrazida. a presente invenção refere-se a novos compostos de hidrazida diarylacetylene de fórmula (i) ou seu sal farmaceuticamente aceitável, tal como inibidores da tirosina quinase, o processo para a sua preparação, e à utilização dos compostos de fórmula geral (i) na preparação de composições farmacêuticas para o tratamento terapêutico de desordens relacionadas com a tirosina quinases, em animais de sangue quente. The present invention relates to novel diarylacetylene hydrazide compounds of formula (I) or pharmaceutically acceptable salt thereof, as tyrosine kinase inhibitors, the process for their preparation, and to the use of the compounds of formula (I) in the preparation of pharmaceutical compositions for the therapeutic treatment of disorders related to tyrosine kinases, in warm-blooded animals.</description><language>por</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211214&amp;DB=EPODOC&amp;CC=BR&amp;NR=112013018212B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211214&amp;DB=EPODOC&amp;CC=BR&amp;NR=112013018212B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DIPALI MANUBHAI DESAI</creatorcontrib><creatorcontrib>SABBIRHUSEN YUSUFBHAI CHIMANWALA</creatorcontrib><creatorcontrib>SENGUPTA PRABAL</creatorcontrib><creatorcontrib>VARUN ANILKUMAR MEHTA</creatorcontrib><creatorcontrib>HEMANT ASHVINBHAI CHOKSHI</creatorcontrib><creatorcontrib>THENNATI RAJAMANNAR</creatorcontrib><creatorcontrib>TRINADHA RAO CHITTURI</creatorcontrib><creatorcontrib>CHETAN SURJITSINGH PURI</creatorcontrib><title>Inibidores de tirosino quinase contendo diarilacettleno hidrazida</title><description>inibidores de tirosino quinase contendo diarilacetileno hidrazida. a presente invenção refere-se a novos compostos de hidrazida diarylacetylene de fórmula (i) ou seu sal farmaceuticamente aceitável, tal como inibidores da tirosina quinase, o processo para a sua preparação, e à utilização dos compostos de fórmula geral (i) na preparação de composições farmacêuticas para o tratamento terapêutico de desordens relacionadas com a tirosina quinases, em animais de sangue quente. The present invention relates to novel diarylacetylene hydrazide compounds of formula (I) or pharmaceutically acceptable salt thereof, as tyrosine kinase inhibitors, the process for their preparation, and to the use of the compounds of formula (I) in the preparation of pharmaceutical compositions for the therapeutic treatment of disorders related to tyrosine kinases, in warm-blooded animals.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyzEOwjAMQNEsDAi4QxZGpDpdWGkFghWxV6Y2wlJkl8QsnJ4OHIDpL-8vw-GicheywjUSR5diVdTi6y2KleNo6qxkkQSLZBzZPfMMnkIFP0K4DosH5sqbX1dhezre-vOOJxu4TvOi7EN3BUgNtA3sE6QO2n_dF-HZM-I</recordid><startdate>20211214</startdate><enddate>20211214</enddate><creator>DIPALI MANUBHAI DESAI</creator><creator>SABBIRHUSEN YUSUFBHAI CHIMANWALA</creator><creator>SENGUPTA PRABAL</creator><creator>VARUN ANILKUMAR MEHTA</creator><creator>HEMANT ASHVINBHAI CHOKSHI</creator><creator>THENNATI RAJAMANNAR</creator><creator>TRINADHA RAO CHITTURI</creator><creator>CHETAN SURJITSINGH PURI</creator><scope>EVB</scope></search><sort><creationdate>20211214</creationdate><title>Inibidores de tirosino quinase contendo diarilacettleno hidrazida</title><author>DIPALI MANUBHAI DESAI ; SABBIRHUSEN YUSUFBHAI CHIMANWALA ; SENGUPTA PRABAL ; VARUN ANILKUMAR MEHTA ; HEMANT ASHVINBHAI CHOKSHI ; THENNATI RAJAMANNAR ; TRINADHA RAO CHITTURI ; CHETAN SURJITSINGH PURI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BR112013018212B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>DIPALI MANUBHAI DESAI</creatorcontrib><creatorcontrib>SABBIRHUSEN YUSUFBHAI CHIMANWALA</creatorcontrib><creatorcontrib>SENGUPTA PRABAL</creatorcontrib><creatorcontrib>VARUN ANILKUMAR MEHTA</creatorcontrib><creatorcontrib>HEMANT ASHVINBHAI CHOKSHI</creatorcontrib><creatorcontrib>THENNATI RAJAMANNAR</creatorcontrib><creatorcontrib>TRINADHA RAO CHITTURI</creatorcontrib><creatorcontrib>CHETAN SURJITSINGH PURI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DIPALI MANUBHAI DESAI</au><au>SABBIRHUSEN YUSUFBHAI CHIMANWALA</au><au>SENGUPTA PRABAL</au><au>VARUN ANILKUMAR MEHTA</au><au>HEMANT ASHVINBHAI CHOKSHI</au><au>THENNATI RAJAMANNAR</au><au>TRINADHA RAO CHITTURI</au><au>CHETAN SURJITSINGH PURI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Inibidores de tirosino quinase contendo diarilacettleno hidrazida</title><date>2021-12-14</date><risdate>2021</risdate><abstract>inibidores de tirosino quinase contendo diarilacetileno hidrazida. a presente invenção refere-se a novos compostos de hidrazida diarylacetylene de fórmula (i) ou seu sal farmaceuticamente aceitável, tal como inibidores da tirosina quinase, o processo para a sua preparação, e à utilização dos compostos de fórmula geral (i) na preparação de composições farmacêuticas para o tratamento terapêutico de desordens relacionadas com a tirosina quinases, em animais de sangue quente. The present invention relates to novel diarylacetylene hydrazide compounds of formula (I) or pharmaceutically acceptable salt thereof, as tyrosine kinase inhibitors, the process for their preparation, and to the use of the compounds of formula (I) in the preparation of pharmaceutical compositions for the therapeutic treatment of disorders related to tyrosine kinases, in warm-blooded animals.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language por
recordid cdi_epo_espacenet_BR112013018212B1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Inibidores de tirosino quinase contendo diarilacettleno hidrazida
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T10%3A35%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DIPALI%20MANUBHAI%20DESAI&rft.date=2021-12-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBR112013018212B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true